ID

29868

Description

Study ID: 104864-201 Clinical Study ID: 104864/A201 Study Title: A Phase III, Open-Label, Multicenter, Randomized, Comparative Study of Topotecan, Ara-C and G-CSF (TAG) versus Idarubicin, Ara-C and G-CSF (IDAG) in MDS Patients with RAEB (High-Risk), RAEB-t or in Patients with AML from a Preceding Phase of MDS Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: hycamtin Study Indication: Myelodysplastic Syndrome https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

Link

https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

Keywords

  1. 4/24/18 4/24/18 - Halim Ugurlu
Copyright Holder

GSK

Uploaded on

April 24, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Study ID 104864-201 Serious Adverse Experience

Serious Adverse Experience (SAE)

Identification Numbers
Description

Identification Numbers

Alias
UMLS CUI-1
C1300638
Center Number
Description

Center Number

Data type

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Description

Patient Initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Serious Adverse Experience (SAE)
Description

Serious Adverse Experience (SAE)

Alias
UMLS CUI-1
C1519255
Person Reporting SAE (Please print clearly)
Description

Person Reporting SAE

Data type

text

Alias
UMLS CUI [1,1]
C0335038
UMLS CUI [1,2]
C1519255
Serious Adverse Experience
Description

Serious Adverse Experience

Data type

text

Alias
UMLS CUI [1]
C1519255
Specify reason(s) for considering this a serious AE. Mark all that apply.
Description

Reason(s) for considering this a serious AE

Data type

text

Alias
UMLS CUI [1]
C3828190
Onset Data and Time
Description

Onset Data and Time

Data type

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0040223
End Date and Time (if ongoing please leave blank)
Description

End Date and Time (if ongoing please leave blank)

Data type

datetime

Alias
UMLS CUI [1]
C2981425
Outcome- If patient died, please complete Form D
Description

Outcome

Data type

text

Alias
UMLS CUI [1]
C1705586
Experience Course
Description

Experience Course

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Common Toxicity Grade: 1-4
Description

Common Toxicity Grade

Data type

text

Alias
UMLS CUI [1]
C2826262
Action Taken with Respect to Investigational Drug
Description

Action Taken with Respect to Investigational Drug

Data type

text

Alias
UMLS CUI [1]
C2826626
Did the SAE abate?
Description

SAE Abate

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C3853704
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)
Description

Study medication reintroduced

Data type

boolean

Alias
UMLS CUI [1,1]
C3854006
UMLS CUI [1,2]
C0580673
If Yes to study medication reintroduced (or dose increased), did SAE recur?
Description

If Yes to study medication reintroduced (or dose increased)

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0034897
Relationship to Investigational Drug
Description

Relationship to Investigational Drug

Data type

text

Alias
UMLS CUI [1,1]
C0439849
UMLS CUI [1,2]
C3854006
What is the SAE probably associated with ?
Description

Assessment of SAE

Data type

text

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1710056
If ´Yes´ record details in the Concomitant Medication section
Description

Corrective Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was patient withdrawn due to this specific SAE?
Description

Withdrawn due to this specific SAE

Data type

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1519255
Relevant Laboratory Data-Test name
Description

Relevant Laboratory Data - Please provide relevant abnormal laboratory data below

Data type

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0027365
Relevant Laboratory Data - Date
Description

Relevant Laboratory Data-Date

Data type

date

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0011008
Relevant Laboratory Data-Value
Description

Relevant Laboratory Data-Value

Data type

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0587081
Relevant Laboratory Data-Units
Description

Relevant Laboratory Data-Units

Data type

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C1519795
Relevant Laboratory Data-Normal Range
Description

Relevant Laboratory Data-Normal Range

Data type

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0086715
Relevant Laboratory Data-Remarks
Description

Remarks (Please provide a brief narrative description of the SAE, attaching extra pages eg. hospital discharge summary if necessary)

Data type

text

Alias
UMLS CUI [1,1]
C0587081
UMLS CUI [1,2]
C1519255
UMLS CUI [1,3]
C0947611
Additional Informations
Description

Additional Informations

Alias
UMLS CUI-1
C1546922
If applicable, was randomisation code broken at investigational site ?
Description

Randomisation code broken at investigational site

Data type

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C1272691
UMLS CUI [1,3]
C2825164
Randomisation/Study Medication Number
Description

Randomisation/Study Medication Number

Data type

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Investigators Signature
Description

Investigators Signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Investigators Signature Date
Description

Investigators Signature Date

Data type

date

Alias
UMLS CUI [1]
C0807937
Please PRINT name
Description

Please PRINT name

Data type

text

Alias
UMLS CUI [1]
C2826892

Similar models

Serious Adverse Experience (SAE)

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Identification Numbers
C1300638 (UMLS CUI-1)
Center Number
Item
Center Number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Serious Adverse Experience (SAE)
C1519255 (UMLS CUI-1)
Person Reporting SAE
Item
Person Reporting SAE (Please print clearly)
text
C0335038 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Serious Adverse Experience
Item
Serious Adverse Experience
text
C1519255 (UMLS CUI [1])
Item
Specify reason(s) for considering this a serious AE. Mark all that apply.
text
C3828190 (UMLS CUI [1])
Code List
Specify reason(s) for considering this a serious AE. Mark all that apply.
CL Item
fatal  (1)
CL Item
life threatening  (2)
CL Item
disabling/incapacitating  (3)
CL Item
results in hospitalization (excluding elective surgery or routine clinical procedures)  (4)
CL Item
hospitalization prolonged  (5)
CL Item
congenital abnormality  (6)
CL Item
cancer  (7)
CL Item
overdose  (8)
CL Item
Investigator considers serious or a significant hazard, contraindication, side effect or precaution (9)
Onset Data and Time
Item
Onset Data and Time
datetime
C0011008 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
End Date and Time (if ongoing please leave blank)
Item
End Date and Time (if ongoing please leave blank)
datetime
C2981425 (UMLS CUI [1])
Item
Outcome- If patient died, please complete Form D
text
C1705586 (UMLS CUI [1])
Code List
Outcome- If patient died, please complete Form D
CL Item
Resolved (1)
CL Item
Ongoing (2)
CL Item
Died (3)
Item
Experience Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Code List
Experience Course
CL Item
Intermittent (number of episodes:..............) (1)
CL Item
Constant (2)
Common Toxicity Grade
Item
Common Toxicity Grade: 1-4
text
C2826262 (UMLS CUI [1])
Item
Action Taken with Respect to Investigational Drug
text
C2826626 (UMLS CUI [1])
Code List
Action Taken with Respect to Investigational Drug
CL Item
None (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Drug stopped (4)
CL Item
Drug interrupted/restarted (5)
CL Item
Dose delayed (6)
CL Item
Dose delayed and decreased (7)
SAE Abate
Item
Did the SAE abate?
boolean
C1519255 (UMLS CUI [1,1])
C3853704 (UMLS CUI [1,2])
Study medication reintroduced
Item
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)
boolean
C3854006 (UMLS CUI [1,1])
C0580673 (UMLS CUI [1,2])
If Yes to study medication reintroduced (or dose increased)
Item
If Yes to study medication reintroduced (or dose increased), did SAE recur?
boolean
C1519255 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
Item
Relationship to Investigational Drug
text
C0439849 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Code List
Relationship to Investigational Drug
CL Item
Not related (4)
CL Item
Unlikely (3)
CL Item
Suspected (reasonable possibility) (2)
CL Item
Probable (1)
Item
What is the SAE probably associated with ?
text
C0085978 (UMLS CUI [1,1])
C1710056 (UMLS CUI [1,2])
Code List
What is the SAE probably associated with ?
CL Item
Protocol design or procedures (but not to study drug) -Please specify:....................... (1)
CL Item
Another Condition (eg, condition under study, intercurrent illness) -Please specify:....................... (2)
CL Item
Another Drug -Please specify:....................... (3)
Corrective Therapy
Item
If ´Yes´ record details in the Concomitant Medication section
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Withdrawn due to this specific SAE
Item
Was patient withdrawn due to this specific SAE?
boolean
C0422727 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Relevant Laboratory Data-Test name
Item
Relevant Laboratory Data-Test name
text
C0022885 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Relevant Laboratory Data-Date
Item
Relevant Laboratory Data - Date
date
C0022885 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Relevant Laboratory Data-Value
Item
Relevant Laboratory Data-Value
text
C0022885 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Relevant Laboratory Data-Units
Item
Relevant Laboratory Data-Units
text
C0022885 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Relevant Laboratory Data-Normal Range
Item
Relevant Laboratory Data-Normal Range
text
C0022885 (UMLS CUI [1,1])
C0086715 (UMLS CUI [1,2])
Relevant Laboratory Data-Remarks
Item
Relevant Laboratory Data-Remarks
text
C0587081 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Item Group
Additional Informations
C1546922 (UMLS CUI-1)
Randomisation code broken at investigational site
Item
If applicable, was randomisation code broken at investigational site ?
boolean
C0034656 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C2825164 (UMLS CUI [1,3])
Randomisation/Study Medication Number
Item
Randomisation/Study Medication Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Investigators Signature
Item
Investigators Signature
text
C2346576 (UMLS CUI [1])
Investigators Signature Date
Item
Investigators Signature Date
date
C0807937 (UMLS CUI [1])
Please PRINT name
Item
Please PRINT name
text
C2826892 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial